Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1971
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study dates from 1971, although not meeting the current acute toxicity guidelines and GLP requirements and lacking described details, the study reveals usefull data considering the LD50 in rats.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1971
Report date:
1971

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
- Principle of test: Oral gavage of very high dose
- Parameters analysed / observed: Mortality, behaviour, signs of toxicity; macroscopic examination
GLP compliance:
no
Test type:
other: Divided doses at 2 h intervals.
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
L-4-hydroxyproline
EC Number:
200-091-9
EC Name:
L-4-hydroxyproline
Cas Number:
51-35-4
Molecular formula:
C5H9NO3
IUPAC Name:
L-4-hydroxyproline
Test material form:
solid: crystalline

Test animals

Species:
rat
Strain:
other: CFY
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Carworth Europe, Huntingdon
- Weight at study initiation: 62 - 123 g
- Fasting period before study: 20 hours before dosing and 4 hours after dosing
- Housing: caged in groups according to sex and age

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: water or methyl cellulose
Details on oral exposure:
Vehicle:
- Concentration in vehicle: 30% solution in water or suspension
Doses:
Test 1: 0, 4, 8, 16 g/kg bw
Test 2: 0, 8.0, 10.0, 12.5, 16.0 g/kg bw
No. of animals per sex per dose:
Test 1: 2 males and 2 females
Test 2: 5 males and 5 females
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: once a week
- Necropsy of survivors performed: yes
- Other examinations performed: body weight/behaviour
Statistics:
Method of Litchfield J.T., Wilcoxon F (1949), J. Pharmac. exp. Ther. 96, 99

Results and discussion

Preliminary study:
The results of the preliminary range finding indicated that the median lethal dose LD50 was in the range of 16000 mg/kg bw.
Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 16 000 mg/kg bw
Based on:
test mat.
Mortality:
Mortality occured 22 hours after dosing
Clinical signs:
other: Lethargic behaviour wa sthe only observed sign of reaction to the treatment.
Gross pathology:
Autopsy did not reveal any specific cause of death.
Other findings:
Recovery of survivors, as jugged by external appearance and behaviour, was apparently complete within 3 days.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
LD50 > 16000 mg/kg
Executive summary:

LD50 > 16000 mg/kg